Table 1.
Indolent lymphoma | Aggressive lymphoma | Highly aggressive lymphoma | Hodgkin lymphoma | p-value | |
---|---|---|---|---|---|
n | 77 | 110 | 6 | 28 | |
Age | < 0.0001 | ||||
Mean ± SD | 72 ± 39 | 66 ± 16 | 41 ± 24 | 41 ± 21 | |
Median | 70 | 70 | 34 | 33 | |
Gender, n [%] | 0.11 | ||||
Male | 37 [48] | 57 [52] | 6 [100] | 14 [50] | |
Female | 40 [52] | 53 [48] | 0 | 14 [50] | |
First Diagnosis, n [%] | 62 [81] | 90 [82] | 5 [83] | 27 [96] | 0.26 |
Time to diagnosis, [Months] | 0.22 | ||||
Mean ± SD | 7.5 ± 11.5 | 3.7 ± 8.5 | 1.5 ± 0.7 | 3.4 ± 3.5 | |
Median | 3.0 | 2.0 | 1.5 | 1.5 | |
Leading symptom | 0.045 | ||||
Cervical mass | 62 [81] | 76 [69] | 3 [100] | 27 [96] | |
Globus pharyngis | 3 [4] | 6 [5] | 0 | 0 | |
Odyno−/dysphagia | 7 [9] | 21 [19] | 3 [100] | 1 [4] | |
Dysphonia | 0 | 1 [1] | 0 | 0 | |
Dyspnea | 2 [3] | 3 [3] | 0 | 0 | |
Incidentally | 2 [3] | 3 [3] | 0 | 0 | |
Localization, n [%] | < 0.0001 | ||||
Major salivary gland | 21 [27] | 12 [11] | 0 | 0 | |
Sinonasal system | 2 [3] | 4 [4] | 0 | 0 | |
Tonsils | 15 [20] | 41 [37] | 3 [50] | 1 [4] | |
Hypopharynx/Larynx | 1 [1] | 6 [6] | 0 | 0 | |
Lymph node | 37 [48] | 43 [39] | 3 [50] | 27 [96] | |
Other | 1 [1] | 4 [4] | 0 | 0 | |
Laterality, n [%] | 0.62 | ||||
Unilateral | 65 [85] | 90 [82] | 6 [100] | 22 [79] | |
Bilateral | 12 [15] | 20 [18] | 0 | 6 [21] | |
Systemic disease, n [%] | 43 [56] | 75 [68] | 6 [100] | 22 [79] | 0.90 |
B-symptoms, n [%] | 5 [7] | 20 [18] | 0 | 3 [11] | 0.30 |
Laboratory parameter, Mean ± SD | |||||
Leucocytes | 11.8 ± 12.0 | 7.7 ± 3.6 | 4.5 ± 3.2 | 8.0 ± 3.0 | 0.043 |
Hemoglobin | 13.6 ± 1.9 | 13.4 ± 2.3 | 10.4 ± 6.1 | 13.0 ± 2.9 | 0.24 |
CRP | 1.53 ± 2.88 | 1.80 ± 3.00 | 1.20 ± 2.00 | 3.30 ± 4.30 | 0.15 |
LDH | 263 ± 285 | 278 ± 291 | 232 ± 229 | 271 ± 121 | 0.97 |
aNHL Aggressive non-Hodgkin lymphoma, haNHL Highly aggressive non-Hodgkin lymphoma, HL Hodgkin lymphoma, iNHL Indolent non-Hodgkin lymphoma